false 0000051143 Capital stock, par value $.20 per share IBM CHX 0000051143 2024-01-29 2024-01-29 0000051143 us-gaap:CommonStockMember exch:XCHI 2024-01-29 2024-01-29 0000051143 us-gaap:CommonStockMember exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes1.125PercentDue2024Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes2.875PercentDue2025Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes0.950PercentDue2025Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes0.875PercentDue2025Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes0.300PercentDue2026Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes1.250PercentDue2027Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes3.375PercentDue2027Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes0.300PercentDue2028Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes1.750PercentDue2028Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes1.500PercentDue2029Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes0.875PercentDue2030Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes1.750PercentDue2031Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes3.625PercentDue2031Member exch:XNYS 2024-01-29 2024-01-29 0000051143 exch:XNYS ibm:Notes0.650PercentDue2032Member 2024-01-29 2024-01-29 0000051143 exch:XNYS ibm:Notes1.250PercentDue2034Member 2024-01-29 2024-01-29 0000051143 ibm:Notes3.750PercentDue2035Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Notes4.875PercentDue2038Member exch:XNYS 2024-01-29 2024-01-29 0000051143 exch:XNYS ibm:Notes1.200PercentDie2040Member 2024-01-29 2024-01-29 0000051143 ibm:Notes4.000PercentDue2043Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Debentures7.00PercentDue2025Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Debentures6.22PercentDue2027Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Debentures6.50PercentDue2028Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Debentures5.875PercentDue2032Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Debentures7.00PercentDue2045Member exch:XNYS 2024-01-29 2024-01-29 0000051143 ibm:Debentures7.125PercentDue2096Member exch:XNYS 2024-01-29 2024-01-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

Title of each class
Trading symbol

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934 

 

Date of Report: January 29, 2024

(Date of earliest event reported)

 

 

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

New York   1-2360   13-0871985
(State of Incorporation)   (Commission File Number)   (IRS employer Identification No.)

 

One New Orchard Road

   
Armonk, New York   10504
(Address of principal executive offices)   (Zip Code)

 

914-499-1900

(Registrant’s telephone number)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange
on which registered
Capital stock, par value $.20 per share   IBM   New York Stock Exchange
        NYSE Chicago
1.125% Notes due 2024   IBM 24A   New York Stock Exchange
2.875% Notes due 2025   IBM 25A   New York Stock Exchange
0.950% Notes due 2025   IBM 25B   New York Stock Exchange
0.875% Notes due 2025   IBM 25C   New York Stock Exchange
0.300% Notes due 2026   IBM 26B   New York Stock Exchange
1.250% Notes due 2027   IBM 27B   New York Stock Exchange
3.375% Notes due 2027   IBM 27F   New York Stock Exchange
0.300% Notes due 2028   IBM 28B   New York Stock Exchange
1.750% Notes due 2028   IBM 28A   New York Stock Exchange
1.500% Notes due 2029   IBM 29   New York Stock Exchange
0.875% Notes due 2030   IBM 30A   New York Stock Exchange
1.750% Notes due 2031   IBM 31   New York Stock Exchange
3.625% Notes due 2031   IBM 31B   New York Stock Exchange
0.650% Notes due 2032   IBM 32A   New York Stock Exchange
1.250% Notes due 2034   IBM 34   New York Stock Exchange
3.750% Notes due 2035   IBM 35   New York Stock Exchange
4.875% Notes due 2038   IBM 38   New York Stock Exchange
1.200% Notes due 2040   IBM 40   New York Stock Exchange
4.000% Notes due 2043   IBM 43   New York Stock Exchange
7.00% Debentures due 2025   IBM 25   New York Stock Exchange
6.22% Debentures due 2027   IBM 27   New York Stock Exchange
6.50% Debentures due 2028   IBM 28   New York Stock Exchange
5.875% Debentures due 2032   IBM 32D   New York Stock Exchange
7.00% Debentures due 2045   IBM 45   New York Stock Exchange
7.125% Debentures due 2096   IBM 96   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

The information set forth in the second and third paragraphs and the last sentence of Item 8.01 of this Current Report on Form 8-K is incorporated by reference herein.

 

Item 8.01. Other Events.

 

On January 29, 2024, IBM International Capital Pte. Ltd. (“IIC”), a private company limited by shares incorporated under the laws of the Republic of Singapore and a 100% owned “finance subsidiary” (as described by the U.S. Securities and Exchange Commission in Rule 13-01(a)(4)(vi) of Regulation S-X) of International Business Machines Corporation (“IBM”), and IBM entered into an underwriting agreement (the “Underwriting Agreement”) with Merrill Lynch (Singapore) Pte. Ltd., Citigroup Global Markets Singapore Pte. Ltd., Goldman Sachs (Singapore) Pte., J.P. Morgan Securities Asia Private Limited and The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch pursuant to which IIC agreed to sell $600,000,000 aggregate principal amount of its 4.700% Notes due 2026, $500,000,000 aggregate principal amount of its 4.600% Notes due 2027, $500,000,000 aggregate principal amount of its 4.600% Notes due 2029, $500,000,000 aggregate principal amount of its 4.750% Notes due 2031, $1,000,000,000 aggregate principal amount of its 4.900% Notes due 2034, $1,000,000,000 aggregate principal amount of its 5.250% Notes due 2044 and $1,400,000,000 aggregate principal amount of its 5.300% Notes due 2054 (together, the “Notes”) and the related guarantee of the Notes in a registered public offering (the “Offering”). The Notes will be fully and unconditionally guaranteed by IBM (the “Guarantee”).

 

On February 2, 2024, IIC and IBM, as guarantor, entered into an indenture (the “Indenture”) with The Bank of New York Mellon, as trustee. The Indenture provides for the issuance of debt securities by IIC and the full and unconditional guarantee of such debt securities by IBM.

 

Under the Indenture, subject to no event of default, IBM has the right, at its option at any time, without the consent of any holders of any series of debt securities, to be substituted for, and assume the obligations of, IIC under each series of debt securities that are then outstanding under the Indenture. The Indenture also contains covenants that limit the aggregate amount of secured indebtedness and sale and leaseback transactions of IBM, subject to exceptions described therein, and restrict IIC’s and IBM’s ability to merge or consolidate unless certain conditions are met.

 

The Notes and the Guarantee will be issued pursuant to the Indenture and the closing of the Offering is expected to occur on February 5, 2024, subject to customary closing conditions.

 

The Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Indenture is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

This Current Report on Form 8-K is also being filed to incorporate by reference into Registration Statement Nos. 333-276739 and 333-276739-01 on Form S-3, effective January 29, 2024, the documents included as (1) Exhibits 4.2, 4.3, 4.4, 4.5, 4.6, 4.7 and 4.8 relating to the Notes and (2) Exhibits 5.1, 5.2, 23.1 and 23.2 regarding the Notes.

 

(d) Exhibits

 

Exhibit No.   Description of Exhibit
1.1   Underwriting Agreement dated January 29, 2024 among IBM International Capital Pte. Ltd., International Business Machines Corporation and Merrill Lynch (Singapore) Pte. Ltd., Citigroup Global Markets Singapore Pte. Ltd., Goldman Sachs (Singapore) Pte., J.P. Morgan Securities Asia Private Limited and The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch, as Underwriters
4.1   Indenture dated as of February 2, 2024, between IBM International Capital Pte. Ltd., International Business Machines Corporation, as guarantor, and The Bank of New York Mellon, as trustee
4.2   Form of 4.700% Note due 2026
4.3   Form of 4.600% Note due 2027
4.4   Form of 4.600% Note due 2029
4.5   Form of 4.750% Note due 2031
4.6   Form of 4.900% Note due 2034
4.7   Form of 5.250% Note due 2044
4.8   Form of 5.300% Note due 2054

 

 

 

 

5.1   Opinion of Frank Sedlarcik, Vice President, Assistant General Counsel and Secretary of IBM regarding the Notes
5.2.   Opinion of Drew & Napier LLC
23.1   Consent of Frank Sedlarcik, Vice President, Assistant General Counsel and Secretary of IBM (included in Exhibit 5.1)
23.2   Consent of Drew & Napier LLC (included in Exhibit 5.2)
104   Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Date:     February 2, 2024

 

  By: /s/ Simon J. Beaumont
    Simon J. Beaumont
    Vice President and Treasurer